Status:
COMPLETED
Vaginal and Rectal Colonization of Lactobacillus Crispatus NTCVAG04 Following Oral Administration in Patients With History of Vaginitis/Vaginosis
Lead Sponsor:
NTC srl
Conditions:
Vaginitis
Vaginosis
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to identify the presence of L. Crispatus in the rectum and vagina after oral administration of BIOVAGINIL by searching for specific DNA of the bacterial strain, to evaluat...
Detailed Description
In fertile, premenopausal healthy women, the vaginal ecosystem is dominated by Lactobacillus spp., but a diverse array of other bacteria can be present in much lower numbers. Over 120 species of Lacto...
Eligibility Criteria
Inclusion
- Female
- Age \> 18 years
- History of vaginitis/vaginosis
- Informed consent
Exclusion
- Pregnancy
- Breastfeeding
- Need for treatment of vaginitis/vaginosis with any antibiotic drug
Key Trial Info
Start Date :
November 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 21 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04676503
Start Date
November 22 2019
End Date
July 21 2020
Last Update
December 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria di Siena - Unità Operativa Semplice Ginecologia Endocrinologica Centro Sterilità di Coppia
Siena, SI, Italy, 53100